Norges Bank Fusion Pharmaceuticals Inc. Transaction History

Norges Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$9.75 - $13.09 $487,500 - $654,500	-50,000 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$11.5 - $13.73 $575,000 - $686,500	50,000 New	50,000 $588,000
Q4 2020 Feb 10, 2021	SELL	$11.5 - $13.73 $575,000 - $686,500	-50,000 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$11.8 - $17.1 $590,000 - $855,000	50,000 New	50,000 $601,000
Q3 2020 Nov 10, 2020	SELL	$11.8 - $17.1 $590,000 - $855,000	-50,000 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$17.0 - $17.78 $850,000 - $889,000	50,000 New	50,000 $874,000

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.